Quantinno Capital Management LP Sells 1,826 Shares of Danaher Co. (NYSE:DHR)

Quantinno Capital Management LP decreased its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 123,626 shares of the conglomerate's stock after selling 1,826 shares during the period. Quantinno Capital Management LP's holdings in Danaher were worth $28,378,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Parkwood LLC bought a new stake in Danaher during the fourth quarter worth about $10,526,000. Mufg Securities Americas Inc. purchased a new stake in shares of Danaher in the fourth quarter worth $2,178,000. Malaga Cove Capital LLC increased its holdings in shares of Danaher by 23.5% during the fourth quarter. Malaga Cove Capital LLC now owns 5,298 shares of the conglomerate's stock valued at $1,216,000 after acquiring an additional 1,007 shares in the last quarter. NorthRock Partners LLC grew its position in Danaher by 129.7% during the 4th quarter. NorthRock Partners LLC now owns 8,323 shares of the conglomerate's stock valued at $1,910,000 after purchasing an additional 4,700 shares during the last quarter. Finally, Nuveen Asset Management LLC increased its stake in Danaher by 2.8% during the 4th quarter. Nuveen Asset Management LLC now owns 4,068,948 shares of the conglomerate's stock valued at $934,027,000 after purchasing an additional 111,894 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Danaher Price Performance

Shares of DHR stock opened at $196.60 on Wednesday. The stock has a 50 day moving average price of $197.83 and a 200 day moving average price of $218.54. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The firm has a market capitalization of $140.70 billion, a P/E ratio of 37.23, a P/E/G ratio of 2.66 and a beta of 0.80.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, sell-side analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.65%. Danaher's payout ratio is 24.85%.

Insider Activity at Danaher

In related news, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 11.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. StockNews.com upgraded Danaher from a "hold" rating to a "buy" rating in a research note on Monday. Stifel Nicolaus upgraded shares of Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective on the stock in a research note on Friday, March 14th. Wells Fargo & Company cut their target price on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research report on Thursday, January 30th. The Goldman Sachs Group cut their price target on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Finally, Jefferies Financial Group lowered their price target on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. Four analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $264.40.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.